IL-18 BPa/IL18BP Antibody (136033) [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # FAB119Y
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 136033
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human IL-18 BPa
Specificity
Detects human IL-18 BPa in direct ELISAs and Western blots. In direct ELISAs and Western blots, does not cross-react with recombinant mouse (rm) IL‑18 BPc or rmIL-18 BPd.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for IL-18 BPa/IL18BP Antibody (136033) [DyLight 680]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-18 BPa
Long Name
Interleukin 18 Binding Protein Isoform a
Alternate Names
IL18 BPa, IL18BP
Gene Symbol
IL18BP
Additional IL-18 BPa Products
Product Documents for IL-18 BPa/IL18BP Antibody (136033) [DyLight 680]
Product Specific Notices for IL-18 BPa/IL18BP Antibody (136033) [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...